MRI-based Computer Aided Diagnosis Software (V1) for Glioma

Launched by MINGGE LLC · Feb 11, 2023

Keywords

ClinConnect Summary

BACKGROUND:

The molecular type is crucial for surgical planning and post-operative treatment of glioma. MRI-based radiomics is an emerging technique that extracts unrevealed information including pathology, biomarkers, and genomics by using automated high-throughput extraction of a large number of quantitative features. With the help of artificial intelligence, MRI-based radiomics could be a promising noninvasive method to reveal molecular type by using a quantitative radiomics approach for glioma.

AIM:

MRI-based computer-aided diagnosis software (V1) is an MRI-based radiomics tool with ...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age front 18 to 70 years old (not including threshold), gender is not limited;
• • 2. Preliminary diagnosis of glioma patients and patients who plan to undergo surgical treatment;
• • 3. Preoperative cranial MRI (T1, T2, T2 Flair, T1 enhanced GE company magnetic resonance package), tumor pathological examination (H\&E section, Kuoran Gene Company package), acceptable follow-up and brain MRI scan;
• • 4. The patient himself voluntarily participated and signed the informed consent in writing.
• Exclusion Criteria:
• • 1. Patients who only underwent biopsy rather than surgical tumor resection;
• • 2. Postoperative pathologically confirmed non-glioma patients;
• • 3. Patients with multiple glioma metastases or multiple gliomas;
• • 4. Patients who died of complications in the early postoperative period;
• • 5. The researcher believes that this researcher should not be included.